About 449 results
Open links in new tab
Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Phase 3 Trial of Tafasitamab in Follicular Lymphoma Meets …
News - Targeted Oncology
Adjuvant T-DM1 Continues to Outperform Trastuzumab in HER2 …
FDA Grants Breakthrough Therapy Designation to Vorasidenib …
FDA Acknowledges BLA of Zolbetuximab in HER2–, CLDN18.2
Authors - Targeted Oncology
Targeting STK11 Mutations in Cancer - Targeted Oncology
Genetic Testing Empowers Better Cancer Care, Prevention, and …
Limited Treatment Options in nccRCC Expanding With IO/TKI …